Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation
Keywords: NQO1; Oridonin; Indolequinone; Hypoxia-selective; Antitumor;